LSE:AZNPharmaceuticals
Is It Too Late To Consider AstraZeneca (LSE:AZN) After A 115% Five Year Run?
Wondering if AstraZeneca shares still offer value after a strong run, or if the current price already reflects the story you are buying into?
The stock last closed at £148.62, with returns of 3.2% over 30 days, 9.3% year to date, 49.4% over 1 year, 31.4% over 3 years, and 115.2% over 5 years. Over the last 7 days, the return was a 2.7% decline.
Recent headlines have continued to focus on AstraZeneca's role as a major global pharmaceuticals player and its broad drug portfolio. This keeps...